| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
146,000,000 |
| Market
Cap: |
16.10(B) |
| Last
Volume: |
3,139,512 |
Avg
Vol: |
1,357,255 |
| 52
Week Range: |
$92.79 - $202.15 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.4 |
| Insider 3/6 Months : 12 |
|
| Guru Rank Number : 691 |
| Guru Rank Value : 2.3 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,330 |
7,330 |
7,330 |
| Total Buy Value |
$0 |
$991,672 |
$991,672 |
$991,672 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
1,315 |
22,740 |
| Total Sell Value |
$0 |
$0 |
$214,105 |
$4,648,975 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
3 |
17 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bowman A Blaine |
Director |
• • – |
2017-05-18 |
4 |
D |
$175.89 |
$200,690 |
D/D |
(1,141) |
14,563 |
|
- |
|
| Epstein Robert S |
Director |
• • – |
2017-05-18 |
4 |
D |
$175.89 |
$200,690 |
D/D |
(1,141) |
5,783 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2017-05-10 |
4 |
AS |
$180.92 |
$417,710 |
D/D |
(2,300) |
15,704 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2017-05-10 |
4 |
OE |
$75.66 |
$174,018 |
D/D |
2,300 |
18,004 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2017-05-09 |
4 |
AS |
$183.30 |
$3,682,718 |
D/D |
(20,000) |
519,176 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2017-05-09 |
4 |
OE |
$36.30 |
$726,000 |
D/D |
20,000 |
539,176 |
|
- |
|
| Bouchard Michel |
Chief Accounting Officer |
• • – |
2017-05-09 |
4 |
AS |
$184.35 |
$1,060,035 |
D/D |
(5,740) |
19,385 |
|
- |
|
| Ostadan Omead |
EVP Ops, Products, Strategy |
• • – |
2017-05-08 |
4 |
AS |
$186.10 |
$311,159 |
D/D |
(1,672) |
27,914 |
|
- |
|
| Thompson John Wendell |
Director |
– • – |
2017-05-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53 |
|
- |
|
| Thompson John Wendell |
Director |
• • – |
2017-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,262 |
4,315 |
|
- |
|
| Dadswell Charles |
Sr VP & General Counsel |
• • – |
2017-05-03 |
4 |
AS |
$187.07 |
$300,996 |
D/D |
(1,609) |
10,936 |
|
- |
|
| Dadswell Charles |
Sr VP & General Counsel |
• • – |
2017-04-24 |
4 |
D |
$180.20 |
$176,416 |
D/D |
(979) |
12,545 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2017-04-12 |
4 |
AS |
$172.46 |
$518,151 |
D/D |
(3,000) |
15,704 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2017-04-12 |
4 |
OE |
$75.66 |
$226,980 |
D/D |
3,000 |
18,704 |
|
- |
|
| Bradbury Daniel |
Director |
• • – |
2017-04-07 |
4 |
AS |
$172.79 |
$103,675 |
D/D |
(600) |
16,465 |
|
- |
|
| Bradbury Daniel |
Director |
• • – |
2017-04-07 |
4 |
OE |
$71.09 |
$42,654 |
D/D |
600 |
17,065 |
|
- |
|
| Ostadan Omead |
EVP Ops, Products, Strategy |
• • – |
2017-03-24 |
4 |
AS |
$170.00 |
$284,240 |
D/D |
(1,672) |
29,586 |
|
- |
|
| Bradbury Daniel |
Director |
• • – |
2017-03-21 |
4 |
AS |
$163.32 |
$98,134 |
D/D |
(600) |
16,465 |
|
- |
|
| Bradbury Daniel |
Director |
• • – |
2017-03-21 |
4 |
OE |
$71.09 |
$42,654 |
D/D |
600 |
17,065 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2017-03-08 |
4 |
AS |
$164.79 |
$494,633 |
D/D |
(3,000) |
15,704 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2017-03-08 |
4 |
OE |
$75.66 |
$226,980 |
D/D |
3,000 |
18,704 |
|
- |
|
| Ronaghi Mostafa |
SVP & CTO |
• • – |
2017-03-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
591 |
65,994 |
|
- |
|
| Bradbury Daniel |
Director |
• • – |
2017-02-17 |
4 |
AS |
$162.80 |
$97,677 |
D/D |
(600) |
16,465 |
|
- |
|
| Bradbury Daniel |
Director |
• • – |
2017-02-17 |
4 |
OE |
$71.09 |
$42,654 |
D/D |
600 |
17,065 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2017-02-15 |
4 |
D |
$163.29 |
$1,685,316 |
D/D |
(10,321) |
79,361 |
|
- |
|
1655 Records found
|
|
Page 34 of 67 |
|
|
1.67 (1.54%) 
